VIK--
VKTX--
vktx glp 1 gip drugs p3 trials bl selling price
$VKTX You're missing the mark on how much money this drug class can make. Viking's GLP-1/GIP drugs are a big deal. The P3 trials will show that. But you think BL should sell it for $120 PPS? That's crazy. Viking's issue is that no one is paying what it's worth and BL won't go below that. So we wait.
Disclaimer: The above is a summary showing certain market information. Ainvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing, All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market.Report an Issue

Comments
No comments yet